VASH1 and cancer: The expression level of VASH1 in WBCs was significantly higher in cancer patients compared to non-cancer controls (1.24 ± 0.06 folds, p = 0.0093 by independent t-tests; Kolmogorov–Smirnov test, p > 0.1500) (Fig. 2 and supplementary Figure S1).